ストックスクリーナーアプリを入手
13.60
2.10%
0.28
アフターアワーズ：
13.59
-0.010
-0.07%
前日終値:
$13.32
開ける：
$13.14
24時間の取引高:
1.64M
Relative Volume:
1.97
時価総額：
$1.45B
収益：
$247.00M
当期純損益:
$-249.00M
株価収益率:
-4.4013
EPS:
-3.09
ネットキャッシュフロー:
$-267.00M
1週間 パフォーマンス:
+9.77%
1か月 パフォーマンス:
+28.42%
6か月 パフォーマンス:
+73.25%
1年 パフォーマンス:
-11.05%
1日の値動き範囲:
$13.05
$13.63
1週間の範囲:
$12.15
$13.63
52週間の値動き範囲:
$6.50
$18.98
Arcus Biosciences Inc Stock (RCUS) Company Profile
名前
Arcus Biosciences Inc
セクター
電話
(510) 694-6200
住所
3928 POINT EDEN WAY, HAYWARD, CA
RCUS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCUS
Arcus Biosciences Inc
|
13.60 | 1.42B | 247.00M | -249.00M | -267.00M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcus Biosciences Inc Stock (RCUS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-26 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-10-21 | 開始されました | H.C. Wainwright | Neutral |
| 2024-10-08 | 開始されました | Wells Fargo | Overweight |
| 2022-11-18 | 開始されました | BofA Securities | Neutral |
| 2022-10-11 | 開始されました | Morgan Stanley | Overweight |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-11-23 | 開始されました | Evercore ISI | Outperform |
| 2020-04-03 | 開始されました | Cantor Fitzgerald | Overweight |
| 2020-03-04 | 開始されました | Barclays | Overweight |
| 2019-11-12 | 開始されました | SunTrust | Buy |
| 2019-09-27 | 開始されました | Mizuho | Buy |
| 2019-05-24 | 再開されました | Citigroup | Buy |
| 2018-10-09 | 開始されました | Wedbush | Outperform |
| 2018-04-09 | 開始されました | Citigroup | Buy |
| 2018-04-09 | 開始されました | Goldman | Neutral |
| 2018-04-09 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Arcus Biosciences Inc (RCUS) 最新ニュース
What analysts say about Arcus Biosciences Inc stockIndustrial Stocks Review & Big Profit Small Investment - earlytimes.in
How to use Fibonacci retracement on Arcus Biosciences Inc.July 2025 PostEarnings & High Yield Stock Recommendations - newser.com
Can momentum traders help lift Arcus Biosciences Inc.July 2025 Decliners & Weekly Top Performers Watchlists - newser.com
Will Arcus Biosciences Inc. stock benefit from sector rotationPortfolio Value Report & Long Hold Capital Preservation Tips - newser.com
Arcus Biosciences Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Technical analysis overview for Arcus Biosciences Inc. stockMarket Activity Summary & Real-Time Sentiment Analysis - newser.com
Arcus Biosciences Inc Stock Analysis and ForecastMarket Rumors and News & Affordable Investment Strategies - earlytimes.in
Published on: 2025-09-29 02:24:19 - newser.com
Voya Investment Management LLC Acquires 17,929 Shares of Arcus Biosciences, Inc. $RCUS - Defense World
Is Arcus Biosciences Inc a good long term investmentDividend Stability Analysis & Maximize Returns With Insights - earlytimes.in
Published on: 2025-09-27 11:46:18 - newser.com
Arcus Biosciences Announces New Employment Inducement Grants - GuruFocus
Cancer-focused Arcus Biosciences Awards 14,650 Combined Equity Grants Under Inducement Plan - Stock Titan
Comparing Pharming Group (NASDAQ:PHAR) and Arcus Biosciences (NYSE:RCUS) - Defense World
Rhumbline Advisers Has $1.44 Million Stock Holdings in Arcus Biosciences, Inc. $RCUS - MarketBeat
Using data models to predict Arcus Biosciences Inc. stock movementGlobal Markets & Smart Swing Trading Alerts - newser.com
Heatmap analysis for Arcus Biosciences Inc. and competitorsJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Arcus Biosciences, Inc. $RCUS Shares Purchased by Rhumbline Advisers - Defense World
Insider Trends: Is Arcus Biosciences Inc still a buy after recent gainsJuly 2025 Sentiment & Risk Managed Investment Entry Signals - خودرو بانک
Goldman Sachs Group Inc. Increases Position in Arcus Biosciences, Inc. $RCUS - MarketBeat
How institutional ownership impacts Arcus Biosciences Inc. stockInsider Buying & Advanced Swing Trade Entry Plans - newser.com
Published on: 2025-09-19 16:30:26 - newser.com
mCRPC Market Trends Point to Steady Growth Ahead by 2034, DelveInsight Analysis Reveals | Janssen R&D, Pfizer, Astellas Pharma, Bristol-Myers Squibb, Promontory Therapeutics, Hinova, Arcus Biosciences - Barchart.com
MACD Signal: Is Arcus Biosciences Inc in a long term uptrendTrade Exit Report & Daily Chart Pattern Signals - خودرو بانک
Market Catalysts: Is Arcus Biosciences Inc. forming higher highs and higher lows2025 Market Sentiment & Growth Focused Stock Reports - خودرو بانک
Jim Cramer on Arcus Biosciences: “Let This Be Your Speculation” - MSN
Forecast Cut: Can Radius Recycling Inc. grow without dilutionWeekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
Trend Review: Is ProShares Trust ProShares Ultra S P500 stock a buy or sellWeekly Investment Recap & Precise Swing Trade Entry Alerts - خودرو بانک
How cyclical is Arcus Biosciences Incs revenue streamMarket Risk Summary & Precise Swing Trade Alerts - خودرو بانک
Can Arcus Biosciences Inc keep up with sector leaders2025 Trade Ideas & Free Fast Gain Swing Trade Alerts - خودرو بانک
Published on: 2025-09-16 14:51:47 - خودرو بانک
Market Fear: What analysts say about Arcus Biosciences Inc. stockJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Growth Value: Can NDRA scale operations efficientlyPortfolio Profit Report & AI Enhanced Trading Signals - khodrobank.com
Retail Surge: Can Arcus Biosciences Inc be recession proofJuly 2025 PreEarnings & Daily Technical Stock Forecast Reports - خودرو بانک
Buyback Watch: Does Arcus Biosciences Inc have a competitive edge2025 Trading Volume Trends & Weekly Watchlist of Top Performers - خودرو بانک
Downgrade Watch: Is Arcus Biosciences Inc stock a buy or sell2025 Support & Resistance & Free High Accuracy Swing Entry Alerts - khodrobank.com
Arcus Biosciences Inc (RCUS) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):